A NON-VIRULENT, SINGLE-DOSE RABIES VACCINE FOR PROPHYLACTIC IMMUNIZATION OF DOGS.

Area of Science:

• Veterinary Virology
• Immunology
• Vaccine Development

Background:

• Developing and testing rabies vaccines necessitates quantitative methodologies.
• Mice, particularly W-Swiss strain, are optimal for vaccine efficacy testing.
• Dogs exhibit variability and susceptibility to infections, limiting their use in comparative vaccine potency testing.

Purpose of the Study:

• To establish quantitative methods for rabies vaccine development and testing.
• To evaluate the efficacy of a novel non-virulent irradiated rabies vaccine.
• To determine optimal virus material requirements for effective vaccine preparation.

Main Methods:

• Utilizing quantitative methods with W-Swiss mice as the primary test animal.
• Employing the Pasteur strain of virus for vaccine preparation.
• Establishing a minimum titre of 330,000 mouse doses per cc. for effective virus material.

Main Results:

• A single injection of the described irradiated vaccine effectively immunizes mice and dogs against virulent rabies virus.
• The novel vaccine demonstrates superior efficacy compared to currently available rabies vaccines.
• Virus-containing brain tissue is identified as the sole potent source for vaccine preparation, excluding most culture vaccines.

Conclusions:

• The developed non-virulent irradiated rabies vaccine offers a highly effective and practical immunization strategy.
• Quantitative testing in mice is crucial for reliable rabies vaccine evaluation.
• Optimized vaccine preparation using specific virus material ensures high potency and efficacy.